61st American Society for Radiation Oncology Annual Meeting (ASTRO), September 2019, Chicago, IL.    First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma undergoing Concurrent Chemoradiation
Abstract for the American Society of Clinical Oncology (ASCO) Annual Meeting, May 29 – Jun 2, 2020, Chicago, IL, Clinical Trials In Progress: BMX-HGG: Phase 2 Trial of Newly Diagnosed High Grade Glioma Treated with Concurrent Radiation Therapy, Temozolomide, and BMX-001

The 2020 MASCC/ISOO Annual Meeting, SEVILLE, SPAIN, 25-27 June, 2020 is postponed to 24-26 June 2021 in the same location – Seville, Spain.  Title:  Cognitive Outcomes of Phase 1 Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients

Share This Webpage

Share this page with your friends!